Jaspe, Jovaida C.
HRN: 20-53-96 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/29/2026
CLINDAMYCIN 150MG/ML, 4ML (AMP)
06/29/2026
07/06/2026
IV
600mg
Q8
DM FOOT, R
Checking Initial Appropriateness
06/29/2026
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
06/29/2026
07/06/2026
IV
1.5g
Q6
UTI
Checking Initial Appropriateness